ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 2888

$1.51M Total Retail Price of All Prescriptions

Rank: 72 out of 2888

1,038 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,038 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

29% of this provider’s 1,038 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 16,347 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,300 804 S3 1 4
LISINOPRIL 711 519 2 3
LEVOTHYROXINE SODIUM 662 506 3 1
OMEPRAZOLE 619 399 4 7
FUROSEMIDE 576 473 5 6
SIMVASTATIN 548 367 6 2
AMLODIPINE BESYLATE 491 360 7 5
METOPROLOL TARTRATE 438 314 8 10
METFORMIN HCL 424 283 9 8
POTASSIUM CHLORIDE 421 355 10 14
GABAPENTIN 408 239 11 13
PREDNISONE 364 232 12 42
ZOLPIDEM TARTRATE 353 204 13 17
HYDROCHLOROTHIAZIDE 350 295 14 15
TRAMADOL HCL 339 246 15 16
PRAVASTATIN SODIUM 326 212 16 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 302 215 17 28
NEXIUM 299 190 18 19
CLOPIDOGREL 298 256 19 30
DONEPEZIL HCL 263 255 20 26
TAMSULOSIN HCL 257 199 21 29
METOPROLOL SUCCINATE 254 189 22 11
MIRTAZAPINE 235 183 23 54
NAMENDA 223 205 24 34
CYMBALTA 211 97 25 44
SERTRALINE HCL 207 151 26 27
MELOXICAM 196 141 27 31
PLAVIX 192 168 28 40
ALENDRONATE SODIUM 186 159 29 23
GLYBURIDE-METFORMIN HCL 178 111 R 30 64
PANTOPRAZOLE SODIUM 166 119 31 33
CRESTOR 163 131 32 20
CARVEDILOL 162 130 33 21
LANTUS 156 110 34 45
AZITHROMYCIN 155 100 35 38
QUETIAPINE FUMARATE 154 121 36 66
ESCITALOPRAM OXALATE 154 128 36 62
CITALOPRAM HBR 148 70 38 24
GLYBURIDE 148 119 R 38 58
ATORVASTATIN CALCIUM 145 122 40 9
RISPERIDONE 144 91 41 72
OLANZAPINE 144 88 41 137
CIPROFLOXACIN HCL 143 105 43 47
EXELON 141 141 44 106
METOCLOPRAMIDE HCL 140 76 45 116
WARFARIN SODIUM 135 111 46 22
ALLOPURINOL 133 110 47 37
PHENYTOIN SODIUM EXTENDED 119 33 48 128
KLOR-CON M20 118 102 49 90
JANUVIA 118 83 49 48
CARBAMAZEPINE 118 36 49 217
FLUOXETINE HCL 117 32 52 83
NOVOLOG 116 75 53 114
LYRICA 116 81 53 69
PAROXETINE HCL 115 61 55 84
AMITRIPTYLINE HCL 115 96 R 55 74
LACTULOSE 112 44 57 111
CYCLOBENZAPRINE HCL 111 60 R 58 68
ISOSORBIDE MONONITRATE ER 111 98 58 51
IBUPROFEN 110 33 60 87
ATENOLOL 108 80 61 25
RANITIDINE HCL 104 71 62 56
DICLOFENAC SODIUM 100 79 63 141
PROMETHAZINE HCL 100 31 R 63 96
CELEBREX 99 83 65 89
CARISOPRODOL 97 37 R 66 82
NIFEDIPINE ER 95 64 67 76
CLONIDINE HCL 94 72 68 39
DIOVAN 94 69 68 35
PROAIR HFA 92 31 70 71
BACLOFEN 92 40 70 121
ABILIFY 90 55 72 172
DOXYCYCLINE HYCLATE 88 56 73 123
INSULIN SYRINGE 87 70 74 86
MECLIZINE HCL 86 67 75 122
LOVASTATIN 85 64 76 41
SPIRONOLACTONE 84 51 77 70
LEVETIRACETAM 83 37 78 103
NAPROXEN 82 39 79 80
DIVALPROEX SODIUM 80 0 80 100
CEPHALEXIN 78 54 81 119
AMOX TR-POTASSIUM CLAVULANATE 74 61 82 112
GEMFIBROZIL 74 37 82 98
CARBIDOPA-LEVODOPA 72 60 84 113
FLUTICASONE PROPIONATE 71 24 85 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 48 86 88
CEFTRIAXONE 70 53 86 281
NYSTATIN 68 46 88 178
AMIODARONE HCL 68 64 88 167
NOVOLIN R 67 52 90 109
ENALAPRIL MALEATE 67 57 90 49
TRIAMCINOLONE ACETONIDE 67 52 90 145
POLYETHYLENE GLYCOL 3350 66 19 93 93
BUSPIRONE HCL 65 42 94 148
LEVOFLOXACIN 64 50 95 57
RAMIPRIL 64 49 95 73
ADVAIR DISKUS 64 34 95 60
EXFORGE 63 43 98 159
TRAZODONE HCL 61 29 99 43
OXYBUTYNIN CHLORIDE ER 60 40 100 132
SUCRALFATE 60 48 100 187
LIDOCAINE HCL 59 47 102 297
AMLODIPINE BESYLATE-BENAZEPRIL 58 36 103 67
DIGOXIN 57 56 104 55
METFORMIN HCL ER 57 34 104 53
SINGULAIR 57 34 104 85
LEVEMIR 54 29 107 135
ACTOS 53 39 108 108
NOVOLIN 70-30 51 37 109 144
GLIPIZIDE 51 48 109 50
AMITIZA 50 0 111 296
FLUCONAZOLE 50 29 111 199
ROPINIROLE HCL 50 42 111 115
TIZANIDINE HCL 50 27 111 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.